Skip to main content
. 2003 Aug 12;89(4):691–696. doi: 10.1038/sj.bjc.6601075

Table 2. Association of Arg462Gln and Asp462Gln genotypes of RNASEL with prostate cancer risk.

  No. of subjects (%)
   
Genotype Case Control OR (95% CI) P-value
Arg462Gln        
 Arg/Arg 69 (68.3%) 71 (67.6%) 1.0 (Ref.)  
 Arg/Gln 32 (31.7%) 26 (24.8%) 1.27 (0.73–2.21) 0.45
 Gln/Gln 0 (0.0%) 8 (7.6%) 0.061 (0.035–0.11) 0.014
         
Asp541Glu        
 Glu/Glu 51 (50.5%) 59 (56.2%) 1.0 (Ref.)  
 Glu/Asp 32 (31.7%) 43 (41.0%) 0.86 (0.49–1.50) 0.62
 Asp/Asp 18 (17.8%) 3 (2.9%) 6.94 (3.98–12.10) 0.0009
         
 Glu/Glu+Glu/Asp 83 (82.2%) 102 (97.1%) 1.0 (Ref.)  
 Asp/Asp 18 (17.8%) 3 (2.9%) 7.37 (4.23–12.86) 0.0004